In this conversation, two pediatric endocrinology specialists, David Cook, MD, FACE and Dr. Laurence Katznelson, MD, join Dr. Carlos Hamilton, Jr. to discuss Therapeutic Goals of Acromegaly.

AACE Clinical Conversation Series - Podcast

Clinical Features, Co-morbidities and Diagnosis of Acromegaly

Therapeutic Goals of Acromegaly

Within the last decade, there have been major advances in the understanding of growth hormone deficiency and its impact on stature, especially short stature. Experts suggest that up to 75% of the cases of growth hormone (GH) deficiency may be reversible. Physicians and endocrinologists now recognize that the growth effects of GH are mediated by a substance called insulin-like growth factor 1 (IGF-1). IGF-1, a potent growth and differentiation factor, stimulates the multiple processes leading to statural growth and is normally secreted in response to stimulation by GH.

Evaluation and Treatment of Growth Failure in Children

In this conversation, two pediatric endocrinology specialists, Dr. Naomi Neufeld and Dr. Paul Saenger, join Dr. Carlos Hamilton, Jr. to discuss current issues surrounding the role of IGF-1 in the treatment of growth failure.

Role of IGF-1 in the Treatment of Growth Failure

Dr. Paul Jellinger, Dr. Joseph Torre and Dr. Vijay Nambi, join Dr. Carlos Hamilton, Jr. to discuss current issues primarily surrounding the prevention of vascular complications in diabetic patients.

Prevention of Vascular Complications in Patients with Diabetes Mellitus

Dr. Joseph Torre and Dr. Addison Taylor, join Dr. Carlos Hamilton, Jr. to discuss current issues surrounding the effects of renal disease in the management of diabetes.

Effects of Renal Disease in the Management of Diabetics

In this conversation, two endocrinologists, Dr. Joseph Torre and Dr. Addison Taylor, join Dr. Carlos Hamilton, Jr. to discuss current issues surrounding the management of hypertension in diabetic patients.

The Management of Hypertension in Diabetic Patients

Dr. Paul Jellinger, Dr. Joseph Torre and Dr. Vijay Nambi, join Dr. Carlos Hamilton, Jr. to discuss current issues primarily surrounding the non-pharmacological management and control of hyperlipidemia in diabetic patients.

Managing Hyperlipidemia in Patients with Diabetes

According to estimates, at least 15% to 30% of hospitalized patients have hyperglycemia or diabetes. A full 2/3 of critical care patients fall into this category, as do 1/3 of cardiac surgery patients. Hyperglycemia is associated with poor outcomes in the inpatient setting, including a higher rate of infection, delayed healing, and more procedure-related complications.

Focus on Inpatient Diabetes Management: Optimizing Glycemic Control

The standard treatment paradigm for newly diagnosed patients with diabetes is counseling the patient about diet and exercise and starting them on an oral agent.

Updates on Treatment Options in the Modern Management of Diabetes

Watch as Dr. Carlos Hamilton asks the tough questions in these 15 minute topical discussions. Each Conversation is a fast-paced discussion between leading experts and is focused on topics that are important to you. You'll hear leading experts explore new research and provide insights into how emerging data affects your clinical practice

hubhopper

AACE Clinical Conversation Series - Podcast

hubhopper